Catalyst Wire Dossier Catalyst Wire Dossier

PRC-063

PRC-063 · Rhodes Pharmaceuticals, L.P.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for PRC-063, covering 2015-07-08 to 2021-07-26. Get the full timeline:

Most recent: Clinical Trial Update: PRC-063 Adult Laboratory Classroom Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

See pricing